Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
33 studies found for:    Benign Essential Blepharospasm
Show Display Options
Rank Status Study
1 Not yet recruiting rTMS and Botulinum Toxin in Benign Essential Blepharospasm
Condition: Benign Essential Blepharospasm
Interventions: Device: Magstim RapidStim2;   Device: Sham Magstim RapidStim2
2 Completed Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Botulinum toxin type A (Dysport®)
3 Completed
Has Results
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
Condition: Focal Dystonia
Interventions: Drug: Acetyl-Hexapeptide Topical Treatment;   Drug: placebo
4 Recruiting Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Procedure: Botulinum toxin A injection (5 sites: 12.5U);   Procedure: Botulinum toxin A injection (4 sites: 10U);   Drug: Botulinum toxin A 12.5U;   Drug: Botulinum toxin A 10U
5 Completed Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Biological: Xeomin®
6 Completed
Has Results
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Biological: Botulinum Toxin Type A 900kDa;   Biological: Botulinum Toxin Type A 150kDa
7 Completed Brain Changes in Blepharospasm
Condition: Blepharospasm
Intervention:
8 Completed Brain Stimulation to Treat Blepharospasm or Meige Syndrome
Conditions: Blepharospasm;   Focal Dystonia
Intervention: Procedure: repetitive transcranial magnetic stimulation (rTMS)
9 Completed Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Korean Botulinum toxin type A (KbtxA) and Botox injection
10 Recruiting Acetyl Hexapeptide-8 for Blepharospasm
Condition: Focal Dystonia
Intervention: Drug: Topical acetyl hexapeptide-8
11 Completed Blepharospasm Patient Survey for Patients With Blepharospasm
Condition: Blepharospasm
Intervention: Other: No intervention- only one time survey
12 Completed Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
Condition: Essential Blepharospasm
Intervention: Drug: Botulinum Toxin Type A
13 Completed
Has Results
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Drug: incobotulinumtoxinA (Xeomin);   Drug: Placebo
14 Completed
Has Results
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Other: No Intervention
15 Terminated Blepharospasm Short Interval
Condition: Blepharospasm
Intervention: Drug: NT 201
16 Completed Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
Condition: Essential Blepharospasm
Interventions: Drug: Hugeltox;   Drug: Botulinum Toxin Type A(Botox®)
17 Not yet recruiting A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Other: No Intervention
18 Not yet recruiting Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm
Condition: Pupillary Occlusion
Intervention:
19 Completed
Has Results
MDs on Botox Utility (MOBILITY)
Conditions: Blepharospasm;   Torticollis;   Strabismus;   Muscle Spasticity
Intervention: Other: botulinum toxin type A
20 Recruiting Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
Condition: Bilateral Blepharospasm (BEB)
Interventions: Drug: IncobulinumtoxinA (Xeomin), 25 Units;   Drug: IncobotulinumtoxinA (Xeomin), 12.5 Units;   Drug: Placebo;   Drug: IncobotulinumtoxinA (Xeomin), 35 Units

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years